Browse the complete record of transactions filed by WITTE OWEN N., Director. Director active across 2 companies, notably Allogene Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Total volume traded: €940k. The latest transaction was filed on 22 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Owen N. Witte is a Director at Allogene Therapeutics, Inc., a company specializing in gene therapies. In his role, he contributes to the strategy and governance of the firm, ensuring that Allogene meets industry standards and shareholder expectations.